Seeking Alpha

BLUE
  bluebird bio, Inc. - NASDAQ

8/20/2014, 9:27 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
BLUE vs. ETF Alternatives
Company Description
bluebird bio Inc is a clinical-stage biotechnology focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy products. Its products portfolio consists of Lenti-D; LentiGlobin; and SCD.
Sector: Healthcare
Industry: Biotechnology
Country: United States